Helena Edlund
individual
About
Helena Edlund is a Swedish molecular biologist and professor of Molecular Developmental Biology at Umea University, with longstanding research leadership in pancreas development, beta-cell function, diabetes, and metabolic disease. She is a scientific founder of Amplifier Therapeutics and a cofounder/shareholder of Betagenon AB, where her research contributed to the AMPK activator program ATX-304/O304. Her profile is primarily that of a scientist, advisor, and biotech founder rather than a fund manager or documented capital deployer.
Areas of interest
longevitybiotechaging-related diseasesmetabolic disorderstype 2 diabetescardiometabolic diseasepancreas developmentbeta-cell functionmolecular biologydevelopmental biology